Jianlin J Chu, 537 Irene Rd, Bedford, MA 01730
Jianlin Chu Phones & Addresses
27 Liberty Rd, Bedford, MA 01730 781-5386339
Des Plaines, IL
1 Watermill Pl, Arlington, MA 02476 781-6437034
7545 Tree Ln, Madison, WI 53717
234 Randolph Dr, Madison, WI 53717
4801 Sheboygan Ave, Madison, WI 53705 608-2743568
Chicago, IL
Peoria, IL
27 Liberty Rd, Bedford, MA 01730
Education
Degree:
Graduate or professional degree
Mentions for Jianlin J Chu
Publications & IP owners
Us Patents
Mesenchymal Stromal Cells And Uses Related Thereto
US Patent:
2013018, Jul 18, 2013
Filed:
Nov 30, 2012
Appl. No.:
13/691349
Inventors:
Robert LANZA - Clinton MA, US
Jianlin CHU - Bedford MA, US
Nicholas Arthur KOURIS - Hudson MA, US
Jianlin CHU - Bedford MA, US
Nicholas Arthur KOURIS - Hudson MA, US
Assignee:
ADVANCED CELL TECHNOLOGY, INC. - Marlborough MA
International Classification:
C12N 5/071
US Classification:
424 937, 435377, 435366, 435325
Abstract:
The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and method sof treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
Mesenchymal Stromal Cells And Uses Related Thereto
US Patent:
2014007, Mar 13, 2014
Filed:
May 30, 2013
Appl. No.:
13/905526
Inventors:
Robert LANZA - Clinton MA, US
Jianlin CHU - Bedford MA, US
Nicholas Arthur KOURIS - Hudson MA, US
Jianlin CHU - Bedford MA, US
Nicholas Arthur KOURIS - Hudson MA, US
International Classification:
A61K 35/28
US Classification:
424 937, 435377, 435366, 435325
Abstract:
The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
Agents And Methods For Modulating Activator Protein-1-Mediated Cellular Processes
US Patent:
2003014, Aug 7, 2003
Filed:
Nov 4, 2002
Appl. No.:
10/287196
Inventors:
Emery Bresnick - Middleton WI, US
Jason Norton - Madison WI, US
Jianlin Chu - Madison WI, US
Jason Norton - Madison WI, US
Jianlin Chu - Madison WI, US
Assignee:
Wisconsin Alumni Research Foundation
International Classification:
A61K038/17
C12Q001/68
G01N033/53
G01N033/567
C12Q001/68
G01N033/53
G01N033/567
US Classification:
514/012000, 435/006000, 435/007200
Abstract:
Agents for modulating AP-1 mediated gene expression are provided. The modulating agents comprise an internalization moiety and: (1) a peptide sequence isolated from the intracellular domain of Notch-1 (NIC-1); or (2) a peptide analogue or peptidomimetic of the NIC-1 peptide sequence. Methods of using the modulating agents for modulating AP-1 mediated gene expression in a variety of contexts (e.g., for modulating inflammatory and immunosuppressive activities) are provided.
Mesenchymal Stromal Cells And Uses Related Thereto
US Patent:
2019017, Jun 13, 2019
Filed:
Sep 7, 2018
Appl. No.:
16/124423
Inventors:
- Marlborough MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Assignee:
Astellas Institute for Regenerative Medicine - Marlborough MA
International Classification:
A61K 35/28
C12N 5/0789
C12N 5/0775
A61K 45/06
A61K 48/00
C12N 5/0789
C12N 5/0775
A61K 45/06
A61K 48/00
Abstract:
The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
Mesenchymal Stromal Cells And Uses Related Thereto
US Patent:
2017025, Sep 7, 2017
Filed:
Mar 23, 2017
Appl. No.:
15/467201
Inventors:
- Marlborough MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Assignee:
Astellas Institute for Regenerative Medicine - Marlborough MA
International Classification:
A61K 35/28
A61K 35/30
A61K 35/34
A61K 35/36
C12N 5/0775
A61K 35/407
C12N 5/077
C12N 5/071
C12N 5/0789
A61K 48/00
A61K 35/39
A61K 35/30
A61K 35/34
A61K 35/36
C12N 5/0775
A61K 35/407
C12N 5/077
C12N 5/071
C12N 5/0789
A61K 48/00
A61K 35/39
Abstract:
The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and method sof treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
Mesenchymal Stromal Cells And Uses Related Thereto
US Patent:
2016003, Feb 11, 2016
Filed:
Oct 1, 2014
Appl. No.:
14/504351
Inventors:
- Marlborough MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Assignee:
Advanced Cell Technology, Inc. - Marlborough MA
International Classification:
A61K 35/28
C12N 5/0775
C12N 5/0775
Abstract:
The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
Mesenchymal Stromal Cells And Uses Related Thereto
US Patent:
2015027, Oct 1, 2015
Filed:
Feb 23, 2015
Appl. No.:
14/629383
Inventors:
- Marlborough MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Robert P. Lanza - Clinton MA, US
Jianlin Chu - Bedford MA, US
Nicholas Arthur Kouris - Hudson MA, US
Assignee:
Ocata Therapeutics, Inc. - Marlborough MA
International Classification:
A61K 35/28
A61K 45/06
A61K 45/06
Abstract:
The present invention generally relates to novel preparations of mesenchymal stromal cells (MSCs) derived from hemangioblasts, methods for obtaining such MSCs, and methods of treating a pathology using such MSCs. The methods of the present invention produce substantial numbers of MSCs having a potency-retaining youthful phenotype, which are useful in the treatment of pathologies.
Possible Relatives
NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.